Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P10
Near historical low
vs 2Y Ago
-0.5x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -53.81% |
| Q3 2025 | -80.35% |
| Q2 2025 | -82.09% |
| Q1 2025 | 199.66% |
| Q4 2024 | -18.50% |
| Q3 2024 | 40.33% |
| Q2 2024 | 4.69% |
| Q1 2024 | 543.39% |
| Q4 2023 | 98.88% |
| Q3 2023 | 123.41% |
| Q2 2023 | -21.94% |
| Q1 2023 | 454.75% |
| Q4 2022 | -95.04% |
| Q3 2022 | -91.36% |
| Q2 2022 | 605.21% |
| Q1 2022 | -3.10% |
| Q4 2021 | 40.56% |
| Q3 2021 | 38.76% |
| Q2 2021 | 8.95% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |